View Clinical Trial (Medical Research Study)
Smoking Cessation Through the Web: Latino Smokers Follow-Up Study
| City: |
|
San Francisco |
| State: |
|
California |
| Zip Code: |
|
94143 |
| Conditions: |
|
Cigarette Smoking - Nicotine Dependence |
| Purpose: |
|
The primary goal of this project is to carry out a randomized controlled trial (RCT)
comparing quit rates of a Spanish/English stop smoking Web site to those of a
no-intervention or "quit on your own" control. The investigators have not included a
no-intervention condition in previous Web studies and although 20% of participants quit
smoking at one year are 20%, obtaining evidence that the investigators interventions yield
higher abstinence rates than a no-intervention control is the next logical step.
Furthermore, although the investigators Web site was designed in English and Spanish, the
investigators success in attracting the U.S. Hispanic/Latino (HL) population in either
language has been limited, so this project only will only conduct intensive telephone
follow-up of HL smokers and add new recruitment methods to do so.
|
| Study Summary: |
|
The main study will randomize participants to one of two conditions, an intervention
condition ("immediate") and a no-intervention control ("delayed"). For the control "quit on
your own" condition, we will offer a 6-month "Delayed" treatment condition (DC) and will
inform participants that we are testing whether smokers who are motivated enough to seek
Internet information on smoking cessation can quit on their own at the same rate as smokers
who are given access to an interactive stop smoking Web site. For our intervention, the
"Immediate" treatment condition (IC) is the UCSF Spanish/English Stop Smoking research Web
site (www.stopsmoking.ucsf.edu) that provides smokers their preference of all elements
tested in earlier trials: 1) a Web version of a National Cancer Institute-designated
evidence-based intervention with updated content, the Guía para Dejar de Fumar; 2) A
document summarizing pharmacological treatment to aide smoking cessation available over the
counter such as nicotine gum or patch or by prescriptions from a clinician; 3) e-mail
reminders to return to the site timed to individually set quit dates; 4) a mood management
smoking cessation intervention; and 5) a virtual group (an asynchronous bulletin board
designed to let participants provide mutual support). We will recruit study participants
until we have randomized 1200 HL smokers in English or Spanish stratified by gender within
language group. Participants will be followed at 1, 3, 6, and 12 months after randomization
to obtain self-reported prolonged abstinence and 7- and 30-day time point prevalence rates.
E-mail reminders will be sent to remind participants to return to the site to complete
follow-up surveys online. Only HL smokers from the US will be followed up by telephone calls
at 1 and 6 months. The main comparison measure will be cessation at 6 and 12 months from
original randomization. DC participants will be able to access the interactive site after
finishing the 6-month follow-up. We plan to attract Spanish-speaking HL participants to our
Web site using Spanish-language TV and radio interviews and public service announcements
(PSA), Spanish-language Google ads and networking with U.S. cessation groups.
|
| Criteria: |
|
Inclusion Criteria:
- age 18 or older
- daily (smoking one or more cigarettes per day) or non-daily (smoke some days) smoker
- planning to quit within the next month
- have a valid e-mail address so to send a password required to consent online.
- speak English or Spanish
- consent to participate
Exclusion Criteria:
- does not speak English or Spanish
- age younger than 18 years
- non-smoker
- no valid email address
|
| NCT ID: |
|
NCT01639079 |
| Primary Contact: |
|
Principal Investigator
Eliseo J Perez-Stable, MD
University of California, San Francisco
Eliseo J. Perez-Stable, MD
Phone: 415 514 8662
Email: eliseops@medicine.ucsf.edu
|
| Backup Contact: |
|
Email: alinne.barrera@ucsf.edu
Alinne Barrera, PhD
|
| Location Contact: |
|
San Francisco, California 94143
United States
Cecilia Populus-Eudave
Phone: 415-502-4088
Email: ceciliap@medicine.ucsf.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|